Elixxer Bought Back and Cancelled 20.6 Million Shares Montreal, Quebec--(Newsfile Corp. - February 7, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased is to provide this update on its previously announced normal course issuer bid (the "Bid"). As of January 31, 2022, the Company has bought back for cancellation a total of 20,632,000 common shares on the open market at prices ranging from $0.01 to $0.02 per share, representing approximately 36.81% of the maximum number of common shares permitted to be purchased pursuant to the Bid. It is the Company's intention to continue to repurchase shares for the foreseeable future to the maximum extent pursuant to its Bid.
The Bid was implemented with a view to providing the Company with a more acceptable capital structure as it pursues certain opportunities for its future expansion/acquisition plans. Ferras Zalt (CEO) said, "I believe the shares are undervalued and I am concerned our discounted stock price may attract hostile bids by people looking to buy our assets at a steep discount."
Elixxer would also like to take this opportunity to remind shareholders that its previously announced stock consolidation will go into effect as of market open on February 10, 2022. The Company's common shares will thereafter trade on the basis of one new share for each 100 shares presently held.
About Elixxer Ltd. (www.Elixxer.com)
Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).
Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.